Laurence M. Corash, Chief Medical Officer at CERUS CORP (CERS), bought 86,900 shares at $2.90 ($242K) on 2011-05-02, disclosed to the SEC on 2011-05-06.
Open-market purchase of $242k CERS by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 20,000 | $58K | 24.0% |
| 2 | $2.80 | 20,000 | $56K | 23.2% |
| 3 | $2.73 | 20,000 | $55K | 22.6% |
| 4 | $2.71 | 11,300 | $31K | 12.7% |
| 5 | $2.72 | 15,600 | $42K | 17.6% |
| Total | $2.78 avg | 86,900 |
| $242K |
| 100% |
| Filing → |
| CERS | SELL | 2022-03-15 | $234K | — | Filing → |
| CERS | SELL | 2021-03-16 | $303K | — | Filing → |
| CERS | SELL | 2020-03-24 | $63K | — | Filing → |